GSK to Buy IDRx for $1.15 Billion as Mergers and Acquisitions Pick...

shared a link

2025-01-14 21:00:02

GSK to Buy IDRx for $1.15 Billion as Mergers and Acquisitions Pick up Steam in 2025

IDRx is a clinical-stage company that develops intelligently designed precision therapies for treating gastronomical tumors.Business AnalysisThe year 2025 may turn out to be a good one for mergers and…

0 Comments 0 Shares